China Sky One acquires 13 medical product licenses, shares rally Print E-mail
By Phil Cheng -   
Friday, 08 April 2011 03:38

Shares of China Sky One Medical (NASDAQ:CSKI) were up more than 10% on Thursday after the Chinese pharmaceutical company said it has acquired thirteen production licenses from the Heilongjiang Food and Drug Administration.

The production licenses cover a range of medical products including an eye patch, mouthwash, and a product that stops snoring.

"We are pleased to obtain production licenses for these exciting new products, which as a group we believe will contribute materially to China Sky One's revenue and net income in 2012," said China Sky One’s CEO, Yan-Qing Liu.

The company said it expects to be able to sell the products easily as they fit well with its existing production facilities and sales network.

China Sky One is preparing for trial production, and expects to bring the products to market as soon as the fourth quarter.   As of 3:29 pm EST on Thursday, the company’s shares were up by 24 cents to trade at $3.36.


“Proactiveinvestors is a leading news organisation and event business with offices in New York, Sydney, Toronto and London. The Company is a publisher and is not registered with the US Securities Exchange Commission or Ontario Securities Commission. Please read our full terms and conditions here

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus